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Diseases, Injuries, and Risk Factors in Child
and Adolescent Health, 1990 to 2017
Findings From the Global Burden of Diseases,
Injuries, and Risk Factors 2017 Study
GBD 2017 Child and Adolescent Health Collaborators
IMPORTANCE Understanding causes and correlates of health loss among children and
adolescents can identify areas of success, stagnation, and emerging threats and thereby
facilitate effective improvement strategies.
OBJECTIVE To estimate mortality andmorbidity in children and adolescents from 1990 to
2017 by age and sex in 195 countries and territories.
DESIGN, SETTING, AND PARTICIPANTS This study examined levels, trends, and spatiotemporal
patterns of cause-specific mortality and nonfatal health outcomes using standardized
approaches to data processing and statistical analysis. It also describes epidemiologic
transitions by evaluating historical associations between disease indicators and the
Socio-Demographic Index (SDI), a composite indicator of income, educational attainment,
and fertility. Data collected from 1990 to 2017 on children and adolescents from birth
through 19 years of age in 195 countries and territories were assessed. Data analysis occurred
from January 2018 to August 2018.
EXPOSURES Being under the age of 20 years between 1990 and 2017.
MAIN OUTCOMES ANDMEASURES Death and disability. All-cause and cause-specific deaths,
disability-adjusted life years, years of life lost, and years of life lived with disability.
RESULTS Child and adolescent deaths decreased 51.7% from 13.77 million (95% uncertainty
interval [UI], 13.60-13.93million) in 1990 to 6.64million (95%UI, 6.44-6.87million) in 2017,
but in 2017, aggregate disability increased 4.7% to a total of 145million (95%UI, 107-190
million) years lived with disability globally. Progress was uneven, and inequity increased, with
low-SDI and low-middle–SDI locations experiencing 82.2% (95%UI, 81.6%-82.9%) of deaths,
up from 70.9% (95%UI, 70.4%-71.4%) in 1990. The leading disaggregated causes of
disability-adjusted life years in 2017 in the low-SDI quintile were neonatal disorders, lower
respiratory infections, diarrhea, malaria, and congenital birth defects, whereas neonatal
disorders, congenital birth defects, headache, dermatitis, and anxiety were highest-ranked in
the high-SDI quintile.
CONCLUSIONS AND RELEVANCE Mortality reductions over this 27-year periodmean that
children are more likely than ever to reach their 20th birthdays. The concomitant expansion
of nonfatal health loss and epidemiological transition in children and adolescents, especially
in low-SDI andmiddle-SDI countries, has the potential to increase already overburdened
health systems, will affect the human capital potential of societies, andmay influence the
trajectory of socioeconomic development. Continuedmonitoring of child and adolescent
health loss is crucial to sustain the progress of the past 27 years.
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C hildhood and adolescence are vulnerable periods andacrucialwindowfor adult healthdetermination.Whileimprovements in themortality rateof childrenyounger
than 5 years (the population often called under-5) have been
undeniably dramatic and positive,1 the full story of child and
adolescent health is more nuanced and heterogeneous, with
anotablybroader rangeof characteristics thancanbe toldwith
a single summary statistic.2 The effects of acute and chronic
infectious diseases, nutrition, physical functioning, mental
health, and intellectual development set the stage for both
individual prosperity and the future human capital of all
societies.3
Elevenof the18SustainableDevelopmentGoals (SDGs)and
19 of the 53 health-associated SDG indicators are about child
andadolescenthealth.4,5These includeendingall formsofmal-
nutrition (SDG2.2), reducingmaternalmortality ratio to fewer
than 70 per 100000 live births (SDG 3.1), decreasing neona-
tal andunder-5mortality rate to fewer than 12and25per 1000
live births, respectively (SDG 3.2), ensuring universal access
to reproductive health care (SDG3.7), andmultiple objectives
aimedat combating specific causes of health loss, such asma-
laria, tuberculosis,HIV, road traffic crashes, air pollution, sub-
stance abuse, and noncommunicable diseases (NCDs). How-
ever,manyof the leadingdriversofhealth loss amongchildren
and adolescents are notably absent from the SDG agenda.6
We have compiled this third annual global report to de-
tail the levels, trends, causes, andcorrelatesofhealth loss from
birth throughage 19years. It reflects several notable improve-
ments fromGlobalBurdenofDisease (GBD)2017.First,wehave
generated a complete set of internally consistent demograph-
ics estimates, with uncertainty intervals (UIs), for age-
specific fertility, population, and all-cause mortality.7 Sec-
ond, 5 additional countries (Ethiopia, Iran, New Zealand,
Norway, and Russia) were estimated at the subnational level.
Third, inaddition toaddingmanynewsourcesofdata,wehave
improved data-processing algorithms. Methods for redistrib-
uting deaths coded to nonspecific, implausible, or intermedi-
ate causes of deathwereupdated to incorporate statistical un-
certainty of cause reassignment. Clinical administrative data
(hospital andclaims)processingmethodswereupdated tobet-
ter account for hospital readmissions,multiple clinical visits,
andorderingofdischargecodesbyage, sex, location, and time.
Fourth,wehave improvedtheepidemiological transitionanaly-
sis through improved estimation of the SDI.
Methods
Comprehensive descriptions of each analytic component of
GBD 2017 are detailed elsewhere1,7-12 and compliant with the
Guidelines for Accurate and Transparent Health Estimates
Reporting.13 TheGBD2017 included 11 467unique sources for
cause of death estimation and 26007 for estimation of non-
fatal health loss.Data sources for each cause-level analysis are
available online at the Global Health Data Exchange.14
The GBD 2017 used a geographic hierarchy of 7 superre-
gions (high-income countries; Latin America and the Carib-
bean; North Africa and the Middle East; South Asia; sub-
SaharanAfrica [SSA];CentralAsia,CentralEurope, andEastern
Europe; and Southeast Asia, East Asia, and Oceania) contain-
ing 21 regions and 195 countries and territories. Fifteen coun-
trieswereestimatedat the subnational level:Brazil, China,En-
gland, Ethiopia, India, Indonesia, Iran, Kenya, Mexico, New
Zealand,Norway, theUnitedStates,Russia, Sweden,andSouth
Africa. Estimates were produced for male individuals and fe-
male individuals separately in eachof 23 standard age groups.
Wecover the first 7of theseagegroups in this report: earlyneo-
natal (0-6 days’ postbirth age), late neonatal (7-27 days’ post-
birth age), postneonatal (28-364 days’ postbirth age), 1 to 4
years, 5 to 9 years, 10 to 14 years, and 15 to 19 years.
Eachof359diseasesand injurieswerearranged ina4-level
mutually exclusive and collectively exhaustive cause hierar-
chy;mostwere analyzed as causing bothdeath anddisability.
The first level (level 1) of the cause list has 3 categories: com-
municable, maternal, neonatal, and nutritional conditions
(CMNN); NCDs; and injuries. At level 2, there are 22 cause
groups, and level 3 includesmoredisaggregatedcausesof bur-
den (169 causes), as does level 4 (293 causes). The full GBD
cause list, including corresponding International Classifica-
tionofDiseases,NinthRevision (ICD-9) andTenthRevision (ICD-
10) codes, is detailed in appendices to the GBD 2017 sum-
mary publications.8,9
All-causemortality, cause-specificmortality, andyears of
life lost (YLLs) were estimated using standardized ap-
proaches of data identification, extraction, and processing to
address data challenges such as incompleteness, variation in
classification systems and coding practices, and inconsistent
age group and sex reporting. Nonfatal estimates were gener-
ated using data from literature, hospital discharge and claims
data systems, cross-sectional surveys, cohort studies, caseno-
tification systems, and disease-specific registries. Cause-
specific years lived with disability (YLDs) were calculated by
multiplying sequela-level prevalencewith correspondingdis-
ability weights that were derived from population and inter-
net surveys ofmore than60000persons and adjusted for co-
morbidity throughmicrosimulation.15,16Disability-adjusted life
years (DALYs) are the sumof YLDs andYLLs andused tomea-
sure thecomprehensivehealthstatusofapopulationforagiven
location, sex, year, and age combination.
Key Points
Question How have the levels, trends, and leading causes of child
and adolescent mortality and nonfatal health loss changed from
1990 to 2017?
Findings This study found that child and adolescent mortality
decreased throughout the world from 1990 to 2017, but morbidity
has increased as a proportion of total disease burden, because the
major causes of nonfatal health loss during childhood and
adolescence have not changed dramatically.
Meaning As the global health community continues to prioritize
child and adolescent health during the Sustainable Development
Goal era, careful attention should also be placed on examining and
addressing nonfatal illness and disability across the development
spectrum.
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We sampled 1000 draws of the posterior distribution of
quantity at themost granular level of each analysis, and 95%
UIs represent the rangeofvaluesbetween theordinal 25thand
975th draws. Unlike confidence intervals, which only cap-
ture sampling error in a single statistical test, UIs also incor-
porate uncertainty fromother associated steps. Aggregate es-
timates (eg,DALYs, combinedagegroups,geographicalgroups)
were calculated by summing draw-level results assuming in-
dependenceof eachquantity.All draw-level resultswere sum-
marized as mean values and 95% UIs.
We performed 3 secondary analyses for this report. First,
we decomposed probability of death from birth to 19 years to
illustrate how cause-specific trends are associatedwith over-
all survival improvements. Second, we explored the histori-
cal association between burden metrics and the SDI, a com-
posite indicator of development based on per capita income,
adult education, and total fertility rate for individuals younger
than 25 years.1 Each GBD location’s SDI can vary by year, but
for reportingpurposes, eachwas assigned to anquintile based
on its SDI in 2017. Amapof SDI quintile assignments is shown
in eFigure 1 in the Supplement and SDI values for each coun-
try by year are in eTable 1 in the Supplement. Observed val-
ues are the actual disease burden rates in each location-year,
while expected values were determined by Gaussian process
regressionon the rangeof rates observed for each level of SDI.
Third, given the intricate association between the health of
women and their children, we examined the historical asso-
ciation between maternal mortality and DALY rates of chil-
dren and adolescents.
We present a number of different formulations of results
in the GBD 2017. Total number illustrates the cumulative size
of burden, ratesbest comparebetweendifferently sizedpopu-
lations, and cause fraction (%) allows the comparison of rela-
tive importance of specific causes. We refer to those younger
than 28 days as neonates, those younger than 1 year as in-
fants, thoseyounger than 10years collectively as children, and
those aged 10 to 19 years as adolescents.We focus on present-
ing aggregate results for the global level, SDI quintiles, and the
GBD regions, either for birth to 19 years en bloc or for infants,
children, and adolescents separately. Except when noted, re-
sults are for both sexes combined. More granular results are
publicly available in an interactive online visualization tool
called GBD Compare (https://vizhub.healthdata.org/gbd-
compare/) and fordownload fromtheGBDResultsTool (http://
ghdx.healthdata.org/gbd-results-tool).
Results
All-CauseMortality and Decomposition of Causes of Death
Prematuremortality is thedominant componentofhealth loss
in children and adolescents. The Table shows deaths by age
groupglobally andbySDIquintile. eTable 2 in theSupplement
shows the same for superregions, regions, countries, and ter-
ritories.All-causechildandadolescentdeathsdecreased51.7%
from13.77million (95%UI, 13.60–13.93million) in 1990 to6.64
million (95% UI, 6.44-6.87 million) in 2017. More than half
(60.1% [95% UI, 59.6%-60.5%]) occurred in infants younger
than 1 year and, of those, 46.6% (95% UI, 46.0%-47.3%) oc-
curred in the first week of life. The fastest declinewas among
children aged 1 to 4 years, in whom global deaths decreased
by 61% from 3.62 million (95% UI, 3.52-3.72 million) in 1990
to 1.40 million (95% UI, 1.34-1.48 million) in 2017. Over the
sameperiod,mortality decreased51% to3.99million (95%UI,
3.85-4.14million) in infantsyounger than1year, by52%to0.41
million (95% UI, 0.40-0.42 million) in children aged 5 to 9
years, and by 27% to 0.84million (95%UI, 0.82-0.85million)
inchildrenaged10to 19years. Improvementsbyageweresimi-
lar across SDI quintiles.
Decomposition of changes in probability of death be-
tween birth and age 20 years from 1990 to 2017 revealed dif-
ferent level 2 cause-level drivers acrossGBD regions (Figure 1;
country results are in eFigure 2 in the Supplement). De-
creases in deaths owing to infectious diseases, neonatal dis-
orders, andunintentional injuries drove improvements at the
global level and for many less-developed regions (eg, CMNN
deathswere virtually absent in high-SDI regions). Inwestern,
central, and eastern SSA, theprobability of surviving to adult-
hood increased from1990 to 2017 (western SSA: 1990, 78.8%;
2017, 89.1%; central SSA: 1990, 80.5%; 2017, 90.7%; eastern
SSA: 1990, 80.0%; 2017, 92.1%), primarily as a result of de-
creased mortality owing to respiratory infections (percent-
age of decreasedmortality owing to this change:western SSA,
20.4%; central SSA, 19.1%; eastern SSA, 17.9%), enteric infec-
tions (western SSA, 24.6%; central SSA, 13.3%; eastern SSA,
13.7%), neglected tropical diseases andmalaria (western SSA,
11.9%; central SSA, 22.6%; eastern SSA, 22.6%), other infec-
tious diseases (western SSA, 25.0%; central SSA, 16.7%; east-
ern SSA, 19.6%), and nutritional deficiencies (western SSA,
6.4%; central SSA, 8.5%; eastern SSA, 7.1%). The total de-
crease in mortality from these causes was 88.4% in western
SSA, 80.3% in central SSA, and 81.0% in eastern SSA.
Decreasedmortality from other NCDs (primarily congen-
ital birth defects and hemoglobinopathies) and neonatal dis-
orders contributed themost to survival improvements inmost
of high-middle–SDI and high-SDI regions (decrease in death
rate, 1990-2017, for congenital birth defects: high-SDI coun-
tries, 52.6% [95% UI, 41.6%-55.8%]; high-middle–SDI coun-
tries,59.4%[95%UI,53.1%-64.8%];hemoglobinopathies:high-
SDI countries, 54.1% [95% UI, 38.8%-60.0%]; high-middle–
SDI countries, 61.3% [95% UI, 49.1%-68.7%]; neonatal
disorders: high-SDI countries, 45.5% [95%UI, 42.3%-50.4%];
high-middle–SDIcountries,65.0%[95%UI,61.3%-68.4%]).Ex-
ceptions to broad survival improvements included a 0.6% in-
creased probability of death owing to HIV/AIDS and sexually
transmitted infections (1990,0.6%; 2017, 1.2%; death rate per
100000population) in individualsyounger than20years from
HIV/AIDS and STI: 1990, 33.6 [95% UI, 22.4-46.7]; 2017, 57.2
[95% UI, 49.5-65.9]) in Southern sub-Saharan Africa.
There were a total of 50 countries where the probability
ofdeathby self-harmand interpersonal violence increasedbe-
tween 1990and2017.Nine of themhad increase ofmore than
0.1% in theoverall probability of deathowing to self-harmand
interpersonal violence between birth and age 20 years: Syria
(1990, 0.04%; 2017, 3.45%), Iraq (1990, 0.26%; 2017, 1.22%),
Yemen (1990, 0.07%; 2017, 0.89%), Central African Republic
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(1990, 0.1%; 2017, 0.64%), South Sudan (1990, 0.35%; 2017,
0.73%), Libya (1990, 0.05%; 2017, 0.41%), Venezuela (1990,
0.19%; 2017, 0.54%),Mexico (1990, 0.17%; 2017, 0.29%), and
Lesotho (1990, 0.25%; 2017, 0.35%).
Temporal and Sociodemographic Trends in DALYs
TotalDALYs inchildrenandadolescentsdecreasedby46%from
1.31 billion (95% UI, 1.27-1.36 billion) in 1990 to 709 million
(95% UI, 665-757 million) in 2017 (Figure 2). Absolute DALYs
decreasesweregreatest in the low-SDIquintile (1990,476mil-
lion [95%UI,464-490million]; 2017, 292million [95%UI, 277-
309million]), but slower relative gains led to increased ineq-
uity as the proportion of global DALYs rose from 36% in 1990
to 41% in 2017. The CMNN causes were by far the largest con-
tributor toDALYs in the low-SDI quintile (75.3%of totalDALYs
[95%UI,73.5%-77.0%]), low-middle–SDIquintile (71.6%of total
DALYs[95%UI,69.6%-73.6%]), andmiddle-SDIquintile (49.8%
of totalDALYs [95%UI, 47.6%-52.0%]) but alsoposted thebig-
gest improvements,decreasinggloballyby52.3%from992mil-
lion (95%UI, 962million-1.025billion) to473million (95%UI,
Figure 1. Decomposition of the Probability of Death Globally and in the Socio-Demographic Index (SDI)
Quintiles and Global Burden of Disease Regions for Individuals Younger Than 20 Years of Both Sexes,
From 1990 to 2017
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452-498 million) in 2017, including a 72.3% reduction in the
middle-SDI quintile from 179 million (95% UI, 172-187 mil-
lion) to 49.5 million (95% UI, 46.5-52.9 million) in 2017. The
NCDDALYrateswere relatively similar acrossSDIquintiles and
had the slowest global decrease (17.1%), from210million (95%
UI, 186-238million) to 174million (95%UI, 151-201million) in
2017. The NCDs were the bulk of DALYs in high-SDI locations
(63.8% [95% UI, 60.1%-67.3%]), while the high-middle–SDI
quintile transitioned in 2000 to also having the largest pro-
portion of child and adolescent DALYs owing to NCDs (1990,
32.0% [95% UI, 29.9%-34.3%]; 2000, 39.2% [95% UI, 36.7%-
41.8%];2017,47.7%[95%UI,44.7%-50.8%]).GlobalDALYsow-
ing to injuries decreased by 46.0% from 113 million (95% UI,
101-122million) to 61.0million (95%UI, 58.0-64.1 million) in
2017but also fluctuatedwidely by country and region,mainly
because of war and (notably) the 1994 Rwandan genocide,
2004 tsunami inSoutheastAsia, the2010earthquake inHaiti,
and other recent conflicts and disasters.
Absolute difference in DALY rates between the lowest-
SDI and highest-SDI locations were more apparent in chil-
drenyounger than5years thanother agegroups (eFigure3and
eFigure 4 in the Supplement). The CMNN category was asso-
ciated with the most DALYs in all SDI quintiles for children
younger than 1 year (DALYs per 100000 population, by SDI:
low, 374 554 [95%UI, 357 5343-392461]; low-middle, 301 824
[95% UI, 278 689-326 511]; middle, 96 368 [95% UI, 92 615-
100368]; high-middle, 48272 [95% UI, 46 183-50491]; high,
21 319 [95%UI, 19936-22 237]). TheNCDs increased in impor-
tancewithage, causing themostDALYs in themiddle-SDIquin-
tile (3355 DALYs [95% UI, 2657-4169] per 100000), high-
middle–SDI quintile (3266 [95%UI, 2570-4102] per 100000),
andhigh-SDIquintile (2938 [95%UI, 2195-3800]per 100000)
in children aged 5 to 9 years, and in all but the low-SDI quin-
tile in children aged 10 to 14 years (per SDI: low-middle quin-
tile, 5116.1 [95% UI, 4061.4-6371.4]; middle quintile, 4503.3
[95% UI, 3519.9-5643.3]; high-middle quintile, 4446.0 [95%
UI, 3453.1-5604.5]; high quintile, 4662.8 [95% UI, 3478.0-
6089.5]) and15 to 19years (perSDI: low-middlequintile, 7266.1
[95% UI, 5839.7-8903.7]; middle quintile, 6370.9 [95% UI,
5039.9-7939.6]; high-middlequintile, 6420.5 [95%UI, 5018.1-
Figure 2. Trends of Disability-Adjusted Life-Years From 1990 to 2017 for Global and Socio-Demographic Index (SDI) Quintiles
for Children and Adolescents Younger Than 20 Years
Communicable, maternal, neonatal, and nutritional diseases
Noncommunicable diseases
Injuries
120 000
96 000
DA
LY
s p
er
 1
00
 0
00
 P
eo
pl
e
72 000
48 000
24 000
1990 2000 2007 2010 2017
Year
1995
GlobalA
1990 2000 2007 2010 2017
Year
1995
Low SDIB
1990 2000 2007 2010 2017
Year
1995
Low-middle SDIC
120 000
96 000
DA
LY
s p
er
 1
00
 0
00
 P
eo
pl
e
72 000
48 000
24 000
1990 2000 2007 2010 2017
Year
1995
Middle SDID
1990 2000 2007 2010 2017
Year
1995
High-middle SDIE
0
0
1990 2000 2007 2010 2017
Year
1995
High SDIF
Temporal trends in disability adjusted life years (DALYs) are plotted for children
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8095.4]; highquintile, 7774.3 [95%UI, 5919.3-9924.6]). In the
low-SDI quintile, NCDs and CMNNDALYs were close in value
(NCDs, children aged 10-14 years, 4990.0 [95% UI, 3908.5-
6217.1] DALYs per 100000; those aged 15-19 years, 7051.07
[95% UI, 5632.0-8659.6] DALYs per 100000; CMNNs: chil-
dren aged 10-14 years, 5843.5 [95%UI, 5016.5-6828.1] DALYs
per 100000; those aged 15-19 years, 5943.6 [95%UI, 5284.8-
6789.5] DALYs per 100000). Despite decreasing rates in 179
of 195 countries between 1990and2017, injuries causedan in-
creasingproportionofoverallDALYswithadvancingageofchil-
dren and adolescents (global rates of injury DALYs per age
group: 10-14 years, 1466.7 [95% UI, 1371.0-1570.3] DALYs per
100000; 15-19 years, 2979.0 [95% UI, 2842.3-3127.0] DALYs
per 100000), to the point that total DALYs owing to injuries
were only marginally lower than CMNN DALYs in those aged
10 to 19years. The sociodemographic gradient for injurieswas
not as stark as for CMNN until the high-SDI quintile
was reached, however. In this quintile, there was a dramatic
decline in injury DALYs compared with other SDI settings
from 1990 to 2017 (low, −58% [95% UI, −64% to −47%]; low-
middle, −48%, [95% UI, −53% to −39%]; middle, −57% [95%
UI, −59% to −57%]; high-middle, −58% [95% UI, −60% to
−56%]; high, −52% [95% UI, −54% to −50%]), but this cat-
egory rose in relative importance to cause nearly 20%of total
DALYs by 2017 in all SDI settings (low, 6.5% [95% UI, 6.0%-
7.1%]; low-middle, 7.5% [95% UI, 7.0%-7.9%]; middle, 14.0%
[95% UI, 13.0%-15.0%]; high-middle, 15.9% [95% UI, 14.7%-
17.2%]; high, 13.5% [95% UI, 12.2%-14.9%]).
Historical patterns inSDI andDALY rates illustrate theepi-
demiologic transitionbyage (eFigure5 in theSupplement).The
slope of the SDI gradient decreasedwith increasing age for all
causes. ForCMNNcauses,DALY rates tracked closelywith SDI
differences in all regions, except Southern sub-SaharanAfrica
and the Caribbean. The association between SDI groups and
NCDswas similar in all children younger than 10 years (range
across all SDI levels: children younger than 1 year, 30413.3-
63 232.9; aged 1-4 years, 3504.3-12 070.2; aged 5-9 years,
3273.1-5017.1), but flattened somewhat in adolescents (range
acrossall SDI levels: aged10-14years,4757.6-5685.7; aged15-19
years, 6835.6-8537.9). In this group, the DALY rate was also
higher. Inseveral regions,asevidencedbysteeptemporal slope
of regional plots, especially inAndeanLatinAmerica andEast
Asia, improvements inNCDDALYsoutpacedwhatwouldhave
been expected on the basis of SDI improvements alone (O:E
DALY rates: Andean Latin America, 1990-2000, −24.1; 2000-
2017, −17.0; East Asia, 1990-2000, 12.2; 2000-2017, −9.1). A
trend toward increasing DALY rates owing to injury in chil-
dren aged 5 to 9 years and 10 to 19 yearswas seen at the lower
endof thedevelopment spectrum.EasternEuropeandSouth-
ern sub-Saharan Africa had consistently higher injury DALY
rates than expected by SDI grouping.
Identifying Exemplars
Changes in the ratio of observed-to-expected (O:E)DALY rates
from 1990 to 2000 and 2000 to 2017 are mapped in Figure 3
(and by age group in eFigure 6 in the Supplement). Before
2000, 117 countries improvedmore than expected on the ba-
sis of SDI changes, while 116 countries did so after 2000. Sev-
enty-six countries had faster than expected improvement in
both periods; the O:E ratio of all-cause DALY rates weremost
notable in Liberia (1990-2000, −35.7; 2000-2017, −30.0), Ni-
ger (1990-2000, −14.7; 2000-2017, −43.3), Kyrgyzstan (1990-
2000,−36.1;2000-2017,−21.0),Peru (1990-2000,−32.8;2000-
2017,−19.0),andGeorgia (1990-2000,−37.6;2000-2017,−12.0).
On the other end of the performance spectrum, 38 countries
performed worse than expected in both periods. From 1990
to 2000,NorthKoreahadO:EDALY rates increase 225%more
than expected. However, many countries that underper-
formed expectations before 2000 reversed course post-
2000. Notable exceptions include Dominica (all-cause O:E
DALY rates: 1990-2000, 31.0; 2000-2017, 99.2), Equatorial
Guinea (all-cause O:E DALY rates: 1990-2000, 41.8; 2000-
2017, 23.1), Bosnia andHerzegovina (all-causeO:EDALY rates:
1990-2000,29.8;2000-2017, 34.2), andLesotho (all-causeO:E
DALY rates: 1990-2000, 46.9; 2000-2017, 14.9).
Syria was also an outlier in how much worse than ex-
pected observedDALY rateswere in children and adolescents
(O:E ratios in 1990: all-cause, 0.48; injuries, 0.49; O:E ratios
in 2017: all-cause, 1.09; injuries, 4.73). Thiswas primarily ow-
ing to increased injury rates (for all individuals younger than
20years: 1990, 189305[95UI, 154987-224769];2017, 1 253214
[95%UI, 1 225825-1288824];percentagechange,562.0%[95%
UI, 462.5%-705.8%]).
Correspondingmaps depicting data for children younger
than 1 year, 1 to 4 years, 5 to 9 years, and 10 to 19 years for
CMNN, NCDs, and injuries separately are shown in eFigure 7
and eTable 3 in the Supplement. For most countries in sub-
Saharan Africa, improvements were much faster than ex-
pected between 2000 and 2017 for children aged 1 to 4 years
in particular, with several countries also having more rapid
DALY improvement than expected in children younger than 1
year and aged 5 to 9 years. Among adolescents, on the other
hand, therewas little evidenceof accelerated improvementaf-
ter the turn of the century, with almost half of the countries
in sub-Saharan Africa lagging behind expected improve-
ments in DALY rates.
Leading Causes of DALYs
The top10 level 3GBDcausesofDALYsglobally in2017 foreach
region and country, along with their O:E DALY rates on the
basis of SDI, are shown in eFigure 8 in the Supplement. Glob-
ally, for all children and adolescents, only 1 primarily nonfa-
tal disease ranked in the top 10 of global DALYs: iron-
deficient anemia (eighth; O:E ratio, 2.08). The rest of the top
10 are also leading causes of death, including neonatal disor-
ders (O:E ratio, 1.38), lower respiratory infection (O:E ratio,
1.83), diarrhea (O:E ratio, 4.96), congenital birth defects (O:E
ratio, 0.78), malaria (O:E ratio, 4596.33), meningitis (O:E ra-
tio, 1.54), road injuries (O:E ratio, 0.69), protein-energy mal-
nutritionO:E ratio, (9.73), andHIV/AIDS (O:E ratio, 10.49). Ev-
ery country in sub-Saharan Africa had either neonatal
disorders,malaria, orHIV/AIDS as the leading cause ofDALYs,
witheitherdiarrheaor lower respiratory infectionoften ranked
second. Neonatal disorders or congenital birth defects were
ranked either first or second in most other countries. Impor-
tant country-specific exceptions included natural disasters
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Figure 3. Percentage Change From 1990 to 2017 in Observed-to-Expected (O:E) Disability-Adjusted Life-Years Ratio
in Children and Adolescents of Both Sexes, Aged 0 to 19 Years
Map of percentage change of observed to expected all-cause DALY rates from 1990 to 2000 in individuals younger than 20 yA
Map of percentage change of observed to expected all-cause DALY rates from 2000 to 2017 in individuals younger than 20 yB
Percentage change O:E DALY
rates, from 2000 to 2017
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≥50%
Percentage changes in observed-to-expected disability-adjusted life-years
(DALYs) are plotted for 1990 to 2017 for all children and adolescents younger
than 20 years. Both sexes are combined. Subnational differentiation occurs
within each country’s Global Burden of Disease models at the subnational level.
Inset plots provided for detailed inspection of small or clustered regions. ATG
indicates Antigua and Barbuda; BRB, Barbados; COM, Comoros; DMA,
Dominica; E Med, Eastern Mediterranean; FJI, Fiji; FSM, Federated States of
Micronesia; GRD, Grenada; KIR, Kiribati; LCA, St Lucia; MDV, Maldives; MHL,
Marshall Islands; MLT, Malta; MUS, Mauritius; SGP, Singapore; SLB, Solomon
Islands; SYC, Seychelles; TLS, Timor-Leste; TON, Tonga; TTO, Trinidad and
Tobago; W Africa, West Africa; WSM, Samoa; VCT, St Vincent and the
Grenadines; and VUT, Vanuatu.
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ranked first in Puerto Rico (O:E ratio, 5993.81), interpersonal
violence ranked second or third in Brazil (O:E ratio, 5.36) and
most of Central Latin America (example O:E ratios: Mexico,
3.59; Honduras, 3.11; Guatemala, 2.74; El Salvador, 5.89; Co-
lombia, 3.36; Panama, 2.84;Venezuela, 7.18), and conflict and
terror ranked first in Syria (O:E ratio, 11 497.8) and second in
Iraq (3204.1) and Libya (O:E ratio, 3442.5).
Also notable was the burden of sudden infant death syn-
drome (SIDS) in infants; SIDSwas ranked third cause ofDALYs
in children younger than 1 year in the high-SDI quintile and in
the top 10 for all high-incomecountries, plus all of EasternEu-
ropeandCentral Europe, accounting for0.71%ofdeaths in the
late neonatal period (age range, 7-27 days) and 2.24% in the
postneonatal period (age range, 28-364 days) in 2017 glob-
ally. Sudden infant death syndrome also accounted for 3.4%
of postneonatal deaths and 17.0%of deaths in the late neona-
tal period in high-SDI locations, but only 0.67% and 2.15% of
deaths, respectively, in low-SDI settings.
The Growing Burden of Nonfatal Health Loss
RatesofYLDsdecreasedonly slightly andnonsignificantlybe-
tween 1990 and 2017. Amidst a backdrop of decreasing pre-
mature childhood death and population growth, global YLDs
increased 4.7% to a total of 145 million (95% UI, 107-190mil-
lion) among children and adolescents. The YLD rates in-
creased with age, from 4366 (3168-5797) per 100000 popu-
lation in childrenyounger than 1 year to4486 (3242-5956) per
100000 population in children aged 1 to 4 years, 4981 (3560-
6619) per 100000population in children aged 5 to 9 years, to
6542 (4845-8493) per 100000population in those aged 10 to
19 years. Temporal trends by region in YLL-to-YLD ratio and
SDI (eFigure 9 in the Supplement) demonstrate an epidemio-
logic transition to nonfatal health loss even more pro-
nounced than the transition in DALYs. The association of the
YLL-to-YLD ratio andSDI categorieswas consistent for CMNN
in all age groups (children younger than 1 year, 67.0 [95% UI,
48.8-90.4]; 1-4years, 6.9 [95%UI, 4.9-9.0]; 5-9years, 1.5 [95%
UI,0.8-1.6]; 10-19years, 1.5 [95%UI,0.8-1.4]) butwas stark for
NCDs in children younger than 1 year (children younger than
1 year, 34.0 [95% UI, 24.7-46.4]; 1-4 years, 2.1 [95% UI,
1.2-2.4]; 5-9years, 0.9 [95%UI,0.3-0.6]; 10-19years, 0.8 [95%
UI, 0.2-0.4]).
In this case, therewas barely any associationbetweenSDI
level and the YLL-to-YLD ratio until the highest SDI strata,
whichmayhave reflectedapoorpenetrationofpreventionand
treatment services for congenital birth defects and neo-
plasmsoutsideof high-incomecountries. In the case ofNCDs,
increasing SDI was associated with an increased YLL-to-YLD
ratio in children aged 5 to 9 years and 10 to 19 years.
Asimilar associationwas found in thecaseof injuries (chil-
drenyounger than1year, 169.2 [95%UI, 117.2-245.8]; 1-4years,
38.7 [95%UI, 27.2-52.7]; 5-9years, 9.4 [95%UI, 6.4-11.7]; 10-19
years, 7.1 [95%UI, 4.8-8.3]). This couldpossibly reflect poorer
prevention and treatment access for these causes and the ef-
fect of wars and natural disasters on disease burden.
In2017, thetop10 level-3causesofYLDsgloballywere iron-
deficient anemia (O:E ratio, 2.08), vitamin A deficiency (O:E
ratio, 1.88), headache (O:E ratio, 0.82), conduct disorder (O:E
ratio, 0.87), neonatal disorders (O:E ratio, 1.13), anxiety disor-
der (O:E ratio, 0.86), skindiseases (O:E ratio, 0.79), lowerback
pain (O:E ratio,0.79), congenitaldisorders (O:E ratio,0.99), and
depression (O:E ratio, 0.87) (eFigure 10 in the Supplement for
results by age). Iron-deficient anemia or asthma sometimes
lead most low and low-middle SDI countries, with neonatal
disorders leading in most middle, high-middle, and high SDI
countries.
Neonatal disorderswas the only level 3 cause that ranked
in the top 10 of bothmortality and disability globally, ranking
among the top 10 causes of YLDs in many countries in North
Africa and theMiddle East and sub-Saharan Africa. Musculo-
skeletal and mental health disorders (including anxiety dis-
orders, conduct disorder, depression, autism spectrumdisor-
ders, and drug use disorders) were all highly ranked in high-
income countries, in central and eastern Europe, and
throughout Asia, Latin America, and the Caribbean. Hemo-
globinopathies, such as sickle cell disorders and thalas-
semias,werealso in the top10byO:Eratio inanumberof coun-
tries, includingYemen (O:E ratio, 2.7),BurkinaFaso (1.74),Côte
d’Ivoire (2.03), Guinea (1.74), Liberia (1.85), Nigeria (3.21), and
SierraLeone(2.32).AmongCMNNcauses,HIV/AIDSwasamong
the top 10 causes ofYLDs inMalawi (O:E ratio, 55.32),Mozam-
bique (O:E ratio, 54.35),Lesotho (O:E ratio, 150.1),Namibia (O:E
ratio, 188.47), South Africa (O:E ratio, 339.23), Eswatini (also
known as Swaziland; O:E ratio, 246.47), and Zimbabwe (O:E
ratio, 58.79). Protein-energy malnutrition was in the top 10
causes in India (O:E ratio, 18.45),Mauritania (O:E ratio, 27.03),
Djibouti (O:E ratio, 13.81), and South Sudan (O:E ratio, 1.82).
Malaria was ranked in the top 5 causes in most countries of
western and central sub-Saharan Africa, as well as Mozam-
bique (O:E ratio, 2.48). Diarrhea, onchocerciasis, and intesti-
nal nematode infectionswere the other CMNN causes among
the top 10 causes of YLDs in certain countries. Injuries didnot
rank high in most countries, with notable exceptions of Iraq
(whereconflict rankedninth;O:Eratio,672.19)andSyria (where
conflict ranked first; O:E ratio, 2962.5).
AssociatingMaternal Health Outcomes
With Those of Children and Adolescents
To evaluate the association between population-level trends
in child and adolescent DALYs and those of theirmothers, we
compared percentage change from 1990 to 2017 in all-cause
DALY rates for children younger than 1 year, 1 to 4 years, 5 to 9
years, and 10 to 19yearswithpercentage change indeath rates
owing to maternal disorders for women aged 10 to 54 years
(eFigure 11 in the Supplement). There were strong correla-
tions between trends in maternal death and all-cause DALY
rates in all childhood age groups (<1 year, r = 0.589; 1-4 years,
r = 0.452; 5-9 years, r = 0.507; 10-19 years, r = 0.379); those
countries with the most improvement in maternal mortality
also tended tohavehigher performance in reducing child and
adolescentdeaths. Statistical correlationwasstrongest for chil-
dren younger than 1 year of age (r = 0.59), but continued even
to health outcomes of older children and adolescents
(r range = 0.38-0.45). The overall association between trends
inmaternalmortality andall-cause child andadolescentDALY
ratesbecamestronger after 2000 inall SDIquintilesother than
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high-middle SDI quintile (low: r = 0.539 in 1990-2000 vs
r = 0.672 in 2000-2017; low-middle: r = 0.540 in 1990-2000
vs r = 0.576 in 2000-2017;middle: r = 0.419 in 1990-2000 vs
r = 0.442 in 2000-2017; high-middle: r = 0.333 in 1990-2000
vs r = 0.296 in 2000-2017; high: r = 0.182 in 1990-2000 vs
r = 0.379 in 2000-2017). A total of 25 countries (Afghanistan,
AmericanSamoa,Antigua, Burundi, Botswana, Canada, Swit-
zerland, Costa Rica, Djibouti, Guam, Jamaica, Kuwait, Leso-
tho, Madagascar, Montenegro, Netherlands, Rwanda, Singa-
pore, Sierra Leone, São Tomé and Principe, Eswatini, Chad,
Thailand, United States, and St Vincent and the Grenadines)
had divergent trends in maternal and child health (ie, 1 mor-
tality rate increasedwhile the other decreased) between 1990
and 2000, while that was only true for 21 countries (Ameri-
canSamoa,Antigua,Bahamas,Barbados,Brunei, Canada,Do-
minican Republic, Georgia, Greece, Grenada, Hungary, Ire-
land,Libya, SaintLucia,Panama,PuertoRico, Suriname,Syria,
United States, St Vincent and the Grenadines, and US Virgin
Islands) from 2000 to 2017. Only 8 countries had divergent
trends throughout the entire time period, with all examples
of divergence having increases inmaternal mortality and de-
creases in all-cause child and adolescent DALY rates: Ameri-
can Samoa (21.5% and −33.1%, respectively), Canada (36.0%
and−20.4%, respectively),Greece (33.8%and−28.5%, respec-
tively), Guam (49.0% and −2.88%, respectively), Jamaica
(4.14% and −28.0%, respectively), St Vincent and the Grena-
dines (7.29% and −24.2%, respectively), the United States
(67.5% and −25.7%, respectively), and Zimbabwe (15.5% and
−10.6%, respectively).
Discussion
Children and adolescents in every country in the world were
more likely to reach their 20th birthday in 2017 than ever be-
fore, but progress in improvinghealth outcomeshas beenun-
even. Mortality reductions were most rapid in children be-
tween the ages of 1 and 4 years, driven by global declines in
deathsowingtodiarrhea, lower respiratory infection,andother
common infectious diseases. Improvements accelerated af-
ter 2000. The largest absolute declineswere seen inWestern,
Eastern, andCentral sub-SaharanAfrica,while the fastest rates
of decline were seen in East Asia, Andean Latin America, and
SouthAsia. Thepattern of changewas closely associatedwith
gains in sociodemographic development and temporally
aligned with increased development assistance for health,
which led to broad improvements in vaccination, early child-
hoodnutrition, sanitation, cleanwater, and targeted interven-
tions for HIV/AIDS andmalaria.3,17-20
A vast unfinished agenda in child and adolescent health
remains.Whilemalaria has decreaseddramatically across the
Africancontinent, therearemanycountries, especially inwest-
ern sub-SaharanAfrica,whereparasite transmission, acute ill-
ness, andmortality frommalaria remain high. Lower respira-
tory infection, diarrhea, and acute malnutrition also remain
among the topkillers of children and adolescents in theworld
in 2017. Investment in programs targeting prevention and ef-
fective syndromic treatment of CMNN disorders clearly pays
dividends, and these investments must continue. In loca-
tions with higher SDIs, a continuing shift toward nonfatal
health loss fromNCDs, such as congenital birth defects,men-
tal and behavioral disorders, injuries, and asthma are chal-
lenging health systems to adapt.21 The consistent burden of
NCD-attributable DALYs in adolescents over the past 28 years
illustrates a need for continued research and action on NCDs
as communicable disease burden declines across the devel-
opment spectrum. The burden of injuries in adolescents sur-
passes that of CMNN causes throughout the study period for
middle-SDI through high-SDI countries, andwith the relative
faster decline of CMNN causes in low and low-middle coun-
tries, the relative ranking of injuries may switch in those lo-
cations in the near future.
Overall health improvements were slowest in adoles-
cents. Few locations showed any evidence of improvements
in health among adolescents that exceeded the trends ex-
pected with general societal development gains. Adoles-
cence is a key phase of the life course and human develop-
ment, including a phase of growth and maturation of the
reproductive, musculoskeletal, neurodevelopmental, endo-
crine, metabolic, immune, and cardiometabolic systems into
adulthood.22 Gains or lack thereof in adolescent health thus
have the potential to influence individual and societal out-
comes for periods substantially longer than the teenageyears.
In terms of family and home life, key issues include the im-
provement of sanitary and living conditions, stable food sys-
tems,quality education, andgainful employment.23Also,HIV/
AIDS remains an imminent threat to the health and well-
being of older children and adolescents in many countries in
sub-Saharan Africa, such as South Africa, Zimbabwe, Leso-
tho, Eswatini, Botswana, and Zambia. The large and growing
burden of mental health and substance use disorders among
older children and adolescents also is an emerging threat to
the thrive component of the SDG survive and thrive agenda.
While the psychological needs of children and adolescents
show similarities across geographical settings,24-27 compara-
tively little is understood about modifiable risk factors or ef-
fectivepreventionprograms for childhoodmental illness, out-
sideof ensuring that caregivers areattuned to the linkbetween
mental health disorders and self-harm.28,29 Injuries in gen-
eral continue to be amajor cause of early mortality and long-
term disability among older children and adolescents in all
countries.Whilemany types of injuries, such as those arising
fromwar and natural disasters, may not be preventable with
health sector–based approaches, diligent preparedness plan-
ning can help mitigate the immediate health aftermath of
them.30-32Othersaremuchmoreamenable topoliciesandpro-
grams that focus on prevention using what have come to be
regardedascommon-sensesafetymeasures, suchasspeed lim-
its, seat belts, and cycle helmets for road traffic accidents,33,34
fencingaroundwaterhazardsandswimming-skills training for
drowning,35 and policies to prevent self-harm via improving
safety and limiting access to firearms and chemicals.36,37
At the other end of the age spectrum, neonatal disorders
remain a major prevention and treatment challenge, espe-
cially for countries outside the high-SDI quintile that lack the
same level of financial andhuman resources todedicate to the
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intensive care needs of sick neonate. Investment is needed to
develop and implement cost-effective interventions for neo-
natal disorders that take into account the dynamics ofmater-
nalhealth, risk-factorexposuresduringpregnancy, clinical care
systems, supportive equipment needs, and the cultural dif-
ferences aroundhow families and communities care for new-
borns. It is important also to invest in the ongoing care of chil-
drenwho surviveperinatal emergencies only todevelop long-
term complications, such as cerebral palsy. Congenital birth
defects and hemoglobinopathies are 2 other groups of causes
for which there is little evidence of improved outcomes out-
side the high-SDI quintile, perhaps reflecting the resource-
intensive nature of averting deaths owing to such conditions
and societal barriers to care38 but also likely because of a fail-
ure of recent clinical advances to be adopted in lower-
resource settings.39
The close linkage between trends in maternal and child
health reinforces the notion that the health of different
population segments are closely interconnected.40 The
simultaneous focus of the Millennium Development Goals
on maternal and child mortality appears to have led to
closer association between them since 2000 via alignment
of funding streams, targeting of common risk factors
between mothers and their children, an increased focus on
delaying the age of parenthood by increasing education,
contraception, and increased birth spacing, and catalyzing
improved gender equity.41-47 There are strong ties between
the physical health of women (eg, high body mass index,
NCDs, nutrition) and neonatal outcomes (such as pregnancy
complications, short gestational age, and low birth weight),
which are in turn linked with poorer health outcomes and
delayed development.3,6 This is to say nothing of the poten-
tial epigenetic connections between mothers and the health
of their children that have the potential to extend beyond
the neonatal period into childhood, adolescence, adult-
hood, and the next generation.48 The subset of countries
that are outliers to this trend of concomitant improvement
in maternal and child health warrant close examination to
determine the underlying causes. Challenges are likely to
arise whenever funding streams are decoupled, education
or family planning programs are disrupted, or the health of
young women is not prioritized.
Theepidemiological transitionhasunique implications for
the health of children and adolescents and the potential tra-
jectory of socioeconomic development. In particular, asmore
children survive, thehumancapital potential societieswill ex-
pand, but asmore childrenwith health problems are also sur-
viving, there is potential for increased burden on health and
educationsystems.Thecostof sustainingprogressonchildand
adolescenthealthandwell-being isnot insignificant.Toachieve
thegoalof survivingand thrivingand realized thehumancapi-
tal potential of children and adolescents, all countries must
make strategic investments in education and health systems,
including human resources for health, supply chains, infra-
structure, governance, and increasedsupport for childrenwith
developmental disabilities. Alignment of funding around in-
terconnected drivers of human development and health loss
is also required to achieve the SDGs.49
The SDGs are expansive, but they should not be consid-
ereda comprehensive rubric for achieving improvedchild and
adolescent health. For example, outside of women’s repro-
ductivehealth andexperiences of sexual violenceduring ado-
lescence, the SDGgoals, targets, and indicators remain largely
silent on theunique social, environmental, andbiological de-
terminants of health occurring in adolescence across the so-
cioeconomic development spectrum.This blind spot in inter-
national health targets, planning, and prevention fails to
capture the complex transitions occurring during adoles-
cence in particular. Many additional nonhealth SDG indica-
tors also focuson reducingpoverty, expandingeducation, sta-
bilizingenvironments, strengtheningeconomies, andreducing
overall socioeconomic inequality within each country and
throughout the world, all of which are relevant to the health
and well-being of young persons.
Limitations
The GBD study is an iterative process and, despite contin-
ued methodological advancements and improvements in
data, this study has a number of limitations. First, all limita-
tions documented in the elements of the GBD estimation
process that allow for YLL, YLD, and DALY estimation will
contribute to uncertainty in these summary measures. Sec-
ond, these summary measures of population health are
influenced by data availability. Time lags in the reporting of
health information by national authorities and thus subse-
quent incorporation into the GBD estimation mean that
these estimates are based on data that are already out of
date. Relatedly, data deficiencies from populations in con-
flict zones (eg, Syria, Iraq, Yemen, South Sudan, Afghani-
stan), autonomous subnational regions, and certain nongeo-
graphical subpopulations (ie, migrants, refugees, and some
indigenous peoples) limit the precision of some of the esti-
mated levels and trends of disease burden. Third, the asso-
ciation between YLLs, YLDs, DALYs, and SDIs, although
explanatory, cannot be viewed as causal. Fourth, a non-
trivial assumption of the analyses is the independence of
the uncertainty calculated for YLLs and YLDs. Because of
the link between death and prevalence, a positive correla-
tion probably exists between these uncertainties that are
not captured in this analysis. Study limitations specific to
child and adolescent health include the comparatively poor
quality of cause-of-death certification in neonates and
infants vs older persons, the relatively broad age categoriza-
tion of all 1-to-4-year-old children in 1 group, and the lim-
ited ability to quantify the magnitude of specific intergen-
erational, societal, and environmental factors that are
ecologically suggested by this study.
Conclusions
Globally, the aggregate health status of children and adoles-
cents improved dramatically between 1990 and 2017, par-
ticularly owing to declines in death owing to infectious dis-
eases, but nonfatal health loss has increased in both
absolute and relative terms, and the gap between best and
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worst performers has widened. Continued monitoring of
the drivers of child and adolescent health loss is crucial to
sustain the progress of the past 26 years in the SDG era. The
global community must commit to creating systematic
accounting of drivers and consequences of long-lasting
negative health outcomes beginning in childhood and the
effects of long-term morbidity on health systems and
human capital and ensuring that no populations are left
behind. Only then will we be able to accelerate progress to
2030 and beyond.
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